Leidos Biomedical Research, Inc. operates the Frederick National L
]aboratory for Cancer Research (FNLCR), a federal national laboratory sponsored by the National Cancer Institute, part of the U.S. National Institutes of Health (NIH). Our employees work in close relationship with NIH researchers to improve human health through discovery and innovation in the biomedical sciences, focusing on cancer, AIDS, and emerging infectious diseases.
We currently have several openings for experienced Clinical Research RNs, Nurse Practitioners and Physician Assistants to provide support to our Clinical Monitoring Research Program (CMRP) at NIH in Bethesda, MD. CMRP provides regulatory and clinical trials management support to over 300 domestic and international clinical trials.
We offer an excellent salary and benefits program, including medical, dental, life, 401(k) retirement savings plan, employee stock purchase plan, gym membership discount, and educational assistance. We believe people are our greatest resource!
If you desire to be part of an organization that is rapidly driving the future of research, explore these exceptional opportunities by applying today.
Leidos Biomed has been the proud recipient of the Maryland Work-Life Alliance “Workplace Excellence” Seal of Approval which recognizes organizations that have embraced work-life practices in order to meet the needs of their workforce, resulting in long-term growth and business success. Leidos Biomed has also been recognized by the Frederick County Office for Children and Families as one of Frederick County’s Top 10 Family Friendly Businesses.
Internal Number: ONS5719
About Leidos Biomedical Research, Inc./ Frederick National Lab for Cancer Research
Leidos Biomedical Research, Inc. (LBRI), a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research (FNLCR). FNLCR is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI). It is the only FFRDC dedicated to biomedical research. Through its status as an FFRDC, FNLCR provides NCI and others with a unique national resource to accelerate the development and delivery of effective preventive, diagnostic, and therapeutic products for cancer and AIDS.The breadth of FNLCR’s activities spans the research and development spectrum, including investigator-initiated, hypothesis-driven research into cancer and AIDS; advanced technology programs focused on genetics and genomics, proteins and proteomics, imaging, nanotechnology, bioinformatics, and laboratory animal sciences; clinical operations in support of NCI and National Institute of Allergy and Infectious Diseases (NIAID)-sponsored clinical trials, as well as NCI drug discovery and development efforts; and management and operations of biopharmaceutical development and manufacturing programs under current Good Manufacturing Practice conditions for NC...I and NIAID. Administrative, procurement, financial, safety, and facilities support is provided to these R&D activities through state-of-the-art business processes. LBRI has approximately 1,900 employees and manages an annual operating budget of approximately $450M. For more information about Leidos Biomedical Research Inc., please visit our webpage at www.leidosbiomed.com. For more information about the Clinical Monitoring Research Program please visit http://cmrp.ncifcrf.gov/CMRP/Default.aspx